REGENERON PHARMACEUTICALS INC. - US75886F1075 (Stock)
TLX
| Price | Diff.% | Date & Time | Bid volume | Bid | Ask | Ask volume |
|---|---|---|---|---|---|---|
458,80 EUR
|
1,5943% | 16.06.2025 17:44 | 26,00 | 452,00 | 464,90 | 26,00 |
| Balance ratios | 2024 | 2023 |
|---|---|---|
| Total assets | 37.852.400 USD | 33.130.600 USD |
| Employees | 15.106 | 13.450 |
| Cash and cash equivalents | 2.488.200 USD | 2.730.000 USD |
| Intangible / inalienable assets | 1.148.600 USD | 1.038.600 USD |
| Economic shareholder's equity | 29.353.600 USD | 25.973.100 USD |
| Subscribed Capital | 100 USD | 100 USD |
| Liabilities | 8.498.800 USD | 7.157.500 USD |
| Liabilities to financial institutions | - | - |
| GuV Zahlen | 2024 | 2023 |
|---|---|---|
| Sales | 14.202.000 USD | 13.117.200 USD |
| Profit after tax | 4.412.600 USD | 3.953.600 USD |
| Deprecation (??) | 482.900 USD | 421.000 USD |
| Dividend ordinary shares | - | - |
| Net investment income | - | - |
| Dividend preferred shares | - | - |
| Net interests income | 656.200 USD | 422.900 USD |
| Earnings from ordinary operating activities | 4.779.900 USD | 4.199.300 USD |
| Net income (after minority interests) | 4.412.600 USD | 3.953.600 USD |
| Net earnings per share | 38.3371 USD | 34.7722 USD |
| Total payout | 0 USD | 0 USD |
| Administrative expenses | - | - |
© 2000 - 2025 UniCredit Bank Austria AG. Please read our terms and conditions
Implemented and powered by FactSet
Fond data is provided from Mountain-View Data Gmbh
Austria-HomePage Version 2.0.54
